Evidence map›Paper›PMID 42892628›Full record

ArticleBlood cancer journal2026

Final analysis results from DREAMM-3, a phase 3 study of belantamab mafodotin versus pomalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Meletios Athanasios Dimopoulos, Vania Hungria, Haitao Meng, Atanas Radinoff, Jian Li, Sosana Delimpasi, Ting Niu, Gabor Mikala, Tamas Masszi, Marcelo Capra and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Meletios Athanasios DimopoulosNational and Kapodistrian University of Athens, Athens, Greece.ORCID http://orcid.org/0000-0001-8990-3254
Vania HungriaDepartment of Hematology, Clinica São Germano São Paulo, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-4327-1957
Haitao MengThe First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Atanas RadinoffUniversity Hospital "St Ivan Rilski" EAD, Sofia, Bulgaria.
Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID http://orcid.org/0000-0002-4549-0694
Sosana DelimpasiGeneral Hospital Evangelismos, Athens, Greece.
Ting NiuWest China Hospital of Sichuan University, Chengdu, Sichuan, China.
Gabor MikalaSouth Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary.
Tamas MassziSemmelweis University Department of Internal Medicine and Hematology, Budapest, Hungary.ORCID http://orcid.org/0000-0003-2322-9863
Marcelo CapraCentro Gaúcho Integrado de Pesquisa, Hospital Mãe de Deus, Porto Alegre, Brazil.ORCID http://orcid.org/0000-0002-5224-1979
Michael LowMonash Haematology, Monash University, Clayton University, Victoria, Australia.
Angelo MaiolinoInstituto Americas de Ensino, Pesquisa e Inovacao, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0003-0140-9548
Yan XuInstitute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China.ORCID http://orcid.org/0000-0002-6167-3319
Xavier LeleuHospital of Poitiers, Poitiers, France.ORCID http://orcid.org/0000-0002-9822-4170
Vasiliki PappaSecond Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital "Attikon", Athens, Greece.ORCID http://orcid.org/0000-0003-0421-9424
Dominik ChraniukDepartment of Hematology, Wojewodzki Szpital Zespolony, Torun, Poland.
Tatiana KonstantinovaRegional Clinical Hospital No 1, Ekaterinburg, Russian Federation.
Iurii OsipovV.A. Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation.
Shawn HakimGSK, Upper Providence, PA, USA.
Chris BrawleyGSK, London, UK.
Gabriela TubelGSK, London, UK.
Astrid McKeownGSK, Stevenage, UK.
Julia BoyleGSK, London, UK.
Sumita Roy-GhantaGSK, Upper Providence, PA, USA.
Katja WeiselUniversity Medical Center of Hamburg-Eppendorf, Hamburg, Germany. k.weisel@uke.de.ORCID http://orcid.org/0000-0001-9422-6614

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42892628
PMCPMC13676618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.